AI-generated summary
The authors report an updated Cochrane systematic review of randomized controlled trials of low level laser therapy for rheumatoid arthritis, pooling five placebo-controlled trials with 222 patients. They found small short-term reductions in pain and morning stiffness compared with placebo, with no differences in function, range of motion or swelling. The authors note the evidence is limited and call for further standardized trials.
- Participants
- 222
- Studies included
- 5
- Who or what was studied
- Patients with a clinical diagnosis of rheumatoid arthritis
- Limits stated in the abstract
- The authors state the analysis lacked data on wavelength, treatment duration, dosage and site of application, and only one study used a contralateral control.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Wavelength, Control group, Heterogeneity, Visual analogue scale, Placebo-controlled, Meta-analysis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.